In head and neck cancer, it has been observed that Gal-1 promotes cellular expression of PD-L1 and Gal-9 at the cell membrane, contributing to early tumor evasion of the T cell-mediated immune response [52]. The gene discussed is CD274; the disease is neoplasm.